Tolmetin Sodium NDC 61825-310

NDC codes

FDA NDC Directory

Product NDC (as listed)61825-310Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61825-0310Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61825-310-30	61825031030	30 CAPSULE in 1 BOTTLE (61825-310-30)Marketed from Mar 19, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tolmetin Sodium
Generic name (nonproprietary): tolmetin sodium
Active ingredients: Tolmetin sodium — 400 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Galt Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 073393
Marketing start: Mar 19, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 61825-310_4d9de430-f193-a927-e063-6294a90a14d4SPL ID 4d9de430-f193-a927-e063-6294a90a14d4SPL set ID 0a97800f-706d-4787-98fe-08dadf9c4d5fRxCUI 198296UNII 02N1TZF99FUPC 0361825310300
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461825031030 followed by a unit qualifier and the quantity

Package 61825-0310-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 22, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Carefully consider the potential benefits and risks of TOLECTIN capsules, USP and other treatment options before deciding to use TOLECTIN capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). TOLECTIN capsules are indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. TOLECTIN capsules are indicated in the treatment of acute flares and the long-term management of the chronic disease. TOLECTIN capsules are also indicated for treatment of juvenile rheumatoid arthritis. The safety and effectiveness of TOLECTIN capsules have not been established in pediatric …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 073393

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073393
Product	Strength	Form · route	Labeler	Product NDC
Tolmetin Sodium	Tolmetin sodium 400 mg/1	CapsuleOral	Atland Pharmaceuticals, LLC	71993-309